1. Home
  2. HURN vs NVCR Comparison

HURN vs NVCR Comparison

Compare HURN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

HOLD

Current Price

$179.26

Market Cap

2.8B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.41

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURN
NVCR
Founded
2002
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
1.5B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
HURN
NVCR
Price
$179.26
$14.41
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$206.75
$28.42
AVG Volume (30 Days)
142.2K
1.4M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
32.32
N/A
EPS
5.98
N/A
Revenue
$1,618,977,000.00
$642,269,000.00
Revenue This Year
$14.19
$9.75
Revenue Next Year
$9.49
$5.62
P/E Ratio
$29.76
N/A
Revenue Growth
12.67
11.17
52 Week Low
$120.25
$10.70
52 Week High
$182.71
$30.78

Technical Indicators

Market Signals
Indicator
HURN
NVCR
Relative Strength Index (RSI) 57.66 67.00
Support Level $169.02 $12.88
Resistance Level $182.68 $13.64
Average True Range (ATR) 4.20 0.50
MACD -0.64 0.12
Stochastic Oscillator 74.76 93.10

Price Performance

Historical Comparison
HURN
NVCR

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: